These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 9017770)

  • 141. Clinical experience with labetalol and enalapril in combination in patients with severe essential and renovascular hypertension.
    White WB; Aydelotte ME
    Am J Med Sci; 1988 Sep; 296(3):187-91. PubMed ID: 2845781
    [TBL] [Abstract][Full Text] [Related]  

  • 142. Antihypertensive safety and efficacy and physician and patient satisfaction: results from a phase 4 practice-based clinical experience trial with diltiazem LA.
    Glasser SP
    Adv Ther; 2006; 23(2):284-94. PubMed ID: 16751161
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Effect of pharmaceutical formulation for diltiazem on health care expenditures for hypertension.
    Skaer TL; Sclar DA; Robison LM; Markowski DJ; Won JK
    Clin Ther; 1993; 15(5):905-11. PubMed ID: 8269458
    [TBL] [Abstract][Full Text] [Related]  

  • 144. Efficacy and safety of clentiazem in patients with essential hypertension: results of an early pilot test.
    Kawakita S; Kinoshita M; Ishikawa H; Kagoshima T; Katori R; Ishikawa K; Hirota Y
    Clin Cardiol; 1991 Jan; 14(1):53-60. PubMed ID: 2019030
    [TBL] [Abstract][Full Text] [Related]  

  • 145. A new extended-release formulation of diltiazem HCl for the treatment of mild-to-moderate hypertension.
    Frishman WH
    J Clin Pharmacol; 1993 Jul; 33(7):612-22. PubMed ID: 8366186
    [TBL] [Abstract][Full Text] [Related]  

  • 146. Bedtime administration of graded-release diltiazem in patients with inadequate BP control: a tolerability and efficacy study.
    Fitchett DH; Casanova A; Jaffer S; Tan M; Kornilova O; Goodman SG; Langer A;
    Am J Cardiovasc Drugs; 2006; 6(6):393-400. PubMed ID: 17192129
    [TBL] [Abstract][Full Text] [Related]  

  • 147. The determinants of response to diltiazem in hypertension.
    Shepherd AM; LeForce C; Park GD; Hoop RS; Weir S
    Clin Pharmacol Ther; 1991 Sep; 50(3):338-49. PubMed ID: 1914368
    [TBL] [Abstract][Full Text] [Related]  

  • 148. Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus.
    Bakris GL
    Ann Intern Med; 1990 May; 112(9):707-8. PubMed ID: 2159250
    [No Abstract]   [Full Text] [Related]  

  • 149. A comparative study of isradipine SRO and enalapril in black patients with mild-to-moderate hypertension.
    Maharaj B; van der Byl K
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):80S-81S. PubMed ID: 8466735
    [TBL] [Abstract][Full Text] [Related]  

  • 150. Antihypertensive and renal effects of enalapril and slow-release verapamil in essential hypertension. A double-blind, randomized study.
    Fagher B; Henningsen N; Hulthén L; Katzman P; Thulin T
    Eur J Clin Pharmacol; 1990; 39 Suppl 1():S41-3. PubMed ID: 2261943
    [TBL] [Abstract][Full Text] [Related]  

  • 151. Comparative effects of diltiazem and hydrochlorothiazide in blacks with systemic hypertension.
    Moser M; Lunn J; Materson BJ
    Am J Cardiol; 1985 Dec; 56(16):101H-104H. PubMed ID: 4072939
    [TBL] [Abstract][Full Text] [Related]  

  • 152. The Hypertension in the Very Elderly Trial (HYVET). Rationale, methodology and comparison with previous trials.
    Bulpitt CJ; Fletcher AE; Amery A; Coope J; Evans JG; Lightowlers S; O'Malley K; Palmer A; Potter J; Sever P
    Drugs Aging; 1994 Sep; 5(3):171-83. PubMed ID: 7803945
    [TBL] [Abstract][Full Text] [Related]  

  • 153. Fatal neonatal renal failure due to maternal enalapril ingestion.
    Murki S; Kumar P; Dutta S; Narang A
    J Matern Fetal Neonatal Med; 2005 Mar; 17(3):235-7. PubMed ID: 16147831
    [TBL] [Abstract][Full Text] [Related]  

  • 154. Persistent dry cough with enalapril: incidence depends on method used.
    Yeo WW; Ramsay LE
    J Hum Hypertens; 1990 Oct; 4(5):517-20. PubMed ID: 2283641
    [TBL] [Abstract][Full Text] [Related]  

  • 155. A dose-response trial of once-daily diltiazem.
    Felicetta JV; Serfer HM; Cutler NR; Comstock TJ; Huber GL; Weir MR; Hafner K; Park GD
    Am Heart J; 1992 Apr; 123(4 Pt 1):1022-6. PubMed ID: 1549966
    [TBL] [Abstract][Full Text] [Related]  

  • 156. [Acute generalised exanthematosus pustulosis (AGEP) due to diltiazem--a case report].
    Barcik K; Protas-Drozd F; Weiss-Rostkowska W; Flis E; Placek W
    Kardiol Pol; 2009 Aug; 67(8):887-91. PubMed ID: 19784887
    [TBL] [Abstract][Full Text] [Related]  

  • 157. Enalapril-associated acute pancreatitis: recurrence after rechallenge.
    Maringhini A; Termini A; Patti R; Ciambra M; Biffarella P; Pagliaro L
    Am J Gastroenterol; 1997 Jan; 92(1):166-7. PubMed ID: 8995963
    [TBL] [Abstract][Full Text] [Related]  

  • 158. [Hemodynamic effects of the treatment of hypertension with the calcium channel blocker diltiazem].
    Ivleva AIa; Moiseev VS; Lepakhin VK; Krasnobaeva GM; Ogoliuk LIu
    Kardiologiia; 1989 Apr; 29(4):58-61. PubMed ID: 2666708
    [TBL] [Abstract][Full Text] [Related]  

  • 159. Proteinuria in essential hypertension.
    Soni PS; Doifode DV; Kate SK
    J Assoc Physicians India; 1994 May; 42(5):379-80. PubMed ID: 7829437
    [TBL] [Abstract][Full Text] [Related]  

  • 160. Effects of diltiazem alone and combined with mefruside on cardiovascular response at rest and during exercise, carbohydrate metabolism and serum lipoproteins in patients with systemic hypertension.
    Schulte KL; Meyer-Sabellek W; Röcker L; Gotzen R; Distler A
    Am J Cardiol; 1987 Oct; 60(10):826-31. PubMed ID: 3661396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.